Loading…
High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium
Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to...
Saved in:
Published in: | Experimental eye research 2023-08, Vol.233, p.109522-109522, Article 109522 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3 |
container_end_page | 109522 |
container_issue | |
container_start_page | 109522 |
container_title | Experimental eye research |
container_volume | 233 |
creator | Okumus, Seydi Ozcan, Eyup Erbagci, Ibrahim |
description | Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium.
•Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium. |
doi_str_mv | 10.1016/j.exer.2023.109522 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2822708407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483523001434</els_id><sourcerecordid>2822708407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EouXxAyyQl7BI8TNOJTao4iUh0QUsWFmOPUldNUmxE0T_HlctLFnNaObeq5mD0AUlE0pofrOcwDeECSOMp8FUMnaAxqnJM0KIOkRjQqjIRMHlCJ3EuExTLpQ4RiOumKKckjGCJ18vsn4RuqFerIceRxsAWt_WuKuw3fSdTbsG8FxIgq9mH_NrXJnGrzbbfQ0tROxbvA6-MWGDTetwADuEAG2P1z2ETe2H5gwdVWYV4XxfT9H7w_3b7Cl7eX18nt29ZJbLvM-4NaS0xjlR5FNROu5EJYQzLs-lFJKWOauqKVdU0UKVzIIzUkJOmKRgqTX8FF3tcteh-xwg9rrx0cJqZVrohqhZwZgihSAqSdlOakMXY4BK73_QlOgtXr3UW7x6i1fv8CbT5T5_KBtwf5ZfnklwuxNA-vLLJ3u0Htp0qU9Yeu06_1_-D7a6i9E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2822708407</pqid></control><display><type>article</type><title>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Okumus, Seydi ; Ozcan, Eyup ; Erbagci, Ibrahim</creator><creatorcontrib>Okumus, Seydi ; Ozcan, Eyup ; Erbagci, Ibrahim</creatorcontrib><description>Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium.
•Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2023.109522</identifier><identifier>PMID: 37271310</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Apoptosis ; Cell proliferation ; CYP ; Cytochrome P-450 CYP11B2 ; Cytochrome P-450 Enzyme System - genetics ; Cytochrome P-450 Enzyme System - metabolism ; High-Throughput Screening Assays ; Humans ; P450 cytochrome ; Pterygium ; Pterygium - metabolism</subject><ispartof>Experimental eye research, 2023-08, Vol.233, p.109522-109522, Article 109522</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</citedby><cites>FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37271310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okumus, Seydi</creatorcontrib><creatorcontrib>Ozcan, Eyup</creatorcontrib><creatorcontrib>Erbagci, Ibrahim</creatorcontrib><title>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium.
•Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.</description><subject>Apoptosis</subject><subject>Cell proliferation</subject><subject>CYP</subject><subject>Cytochrome P-450 CYP11B2</subject><subject>Cytochrome P-450 Enzyme System - genetics</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>High-Throughput Screening Assays</subject><subject>Humans</subject><subject>P450 cytochrome</subject><subject>Pterygium</subject><subject>Pterygium - metabolism</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EouXxAyyQl7BI8TNOJTao4iUh0QUsWFmOPUldNUmxE0T_HlctLFnNaObeq5mD0AUlE0pofrOcwDeECSOMp8FUMnaAxqnJM0KIOkRjQqjIRMHlCJ3EuExTLpQ4RiOumKKckjGCJ18vsn4RuqFerIceRxsAWt_WuKuw3fSdTbsG8FxIgq9mH_NrXJnGrzbbfQ0tROxbvA6-MWGDTetwADuEAG2P1z2ETe2H5gwdVWYV4XxfT9H7w_3b7Cl7eX18nt29ZJbLvM-4NaS0xjlR5FNROu5EJYQzLs-lFJKWOauqKVdU0UKVzIIzUkJOmKRgqTX8FF3tcteh-xwg9rrx0cJqZVrohqhZwZgihSAqSdlOakMXY4BK73_QlOgtXr3UW7x6i1fv8CbT5T5_KBtwf5ZfnklwuxNA-vLLJ3u0Htp0qU9Yeu06_1_-D7a6i9E</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Okumus, Seydi</creator><creator>Ozcan, Eyup</creator><creator>Erbagci, Ibrahim</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202308</creationdate><title>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</title><author>Okumus, Seydi ; Ozcan, Eyup ; Erbagci, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Apoptosis</topic><topic>Cell proliferation</topic><topic>CYP</topic><topic>Cytochrome P-450 CYP11B2</topic><topic>Cytochrome P-450 Enzyme System - genetics</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>High-Throughput Screening Assays</topic><topic>Humans</topic><topic>P450 cytochrome</topic><topic>Pterygium</topic><topic>Pterygium - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okumus, Seydi</creatorcontrib><creatorcontrib>Ozcan, Eyup</creatorcontrib><creatorcontrib>Erbagci, Ibrahim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okumus, Seydi</au><au>Ozcan, Eyup</au><au>Erbagci, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2023-08</date><risdate>2023</risdate><volume>233</volume><spage>109522</spage><epage>109522</epage><pages>109522-109522</pages><artnum>109522</artnum><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>Pterygium is a common degenerative disease characterized by fibrovascular outgrowth towards cornea. Around 200 million people have been reported to be affected by the pterygium in the world. Although the risk factors for pterygium are well documented, the molecular pathogenesis of pterygium seems to be very complex and remains highly elusive. However, the common sense for the development of pterygium appears to be deregulation of growth hemostasis due to aberrant apoptosis. In addition, pterygium shares many features with human cancers, including dysregulation of apoptosis, persistent proliferation, inflammation, invasion, and relapse following resection. Cytochrome P450 (CYP) monooxygenases are a superfamily of heme-containing enzymes with a wide range of structural and functional diversity. In the present study, we aimed to identify significant expression signatures of CYP gene in pterygium. For the study, a total number of 45 patients (30 primary and 15 recurrent pterygium) were included. For the high-throughput screening of CYP gene expression, Fluidigm 96.96 Dynamic Array Expression Chip was used and analyzed with BioMark™ HD System Real-Time PCR system. Remarkably, CYP genes were identified to be significantly overexpressed in both primary and recurrent pterygium samples. Most prominent overexpression was observed in CYP1A1, CYP11B2 and CYP4F2 in primary pterygium and CYP11A1 and CYP11B2 in recurrent pterygium. Consequently, present findings suggest the significant involvement of CYP genes in the development and progression of pterygium.
•Human CYP genes are significantly overexpressed pterygium.•CYP1A1, CYP11B2 and CYP4F2 were upregulated in primary pterygium.•CYP11A1 and CYP11B2 were upregulated in recurrent pterygium.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37271310</pmid><doi>10.1016/j.exer.2023.109522</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4835 |
ispartof | Experimental eye research, 2023-08, Vol.233, p.109522-109522, Article 109522 |
issn | 0014-4835 1096-0007 |
language | eng |
recordid | cdi_proquest_miscellaneous_2822708407 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Apoptosis Cell proliferation CYP Cytochrome P-450 CYP11B2 Cytochrome P-450 Enzyme System - genetics Cytochrome P-450 Enzyme System - metabolism High-Throughput Screening Assays Humans P450 cytochrome Pterygium Pterygium - metabolism |
title | High-throughput screening of cytochrome P450 (CYP) family of genes in primary and recurrent pterygium |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A20%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-throughput%20screening%20of%20cytochrome%20P450%20(CYP)%20family%20of%20genes%20in%20primary%20and%20recurrent%20pterygium&rft.jtitle=Experimental%20eye%20research&rft.au=Okumus,%20Seydi&rft.date=2023-08&rft.volume=233&rft.spage=109522&rft.epage=109522&rft.pages=109522-109522&rft.artnum=109522&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2023.109522&rft_dat=%3Cproquest_cross%3E2822708407%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-3ca0bcadd48694bd3d4f44dad6655451b62ff93717187b2ceda55e60251ec1ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2822708407&rft_id=info:pmid/37271310&rfr_iscdi=true |